Vitalhub (TSE:VHI) Director Francis Nelson Shen Buys 439,600 Shares

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen acquired 439,600 shares of the firm’s stock in a transaction on Tuesday, March 24th. The shares were bought at an average cost of C$7.00 per share, with a total value of C$3,077,200.00. Following the completion of the acquisition, the director owned 588,300 shares in the company, valued at C$4,118,100. This represents a 295.63% increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Thursday, March 26th, Francis Nelson Shen bought 50,000 shares of Vitalhub stock. The stock was bought at an average price of C$6.99 per share, for a total transaction of C$349,500.00.

Vitalhub Stock Performance

Shares of Vitalhub stock opened at C$6.95 on Friday. Vitalhub Corp. has a 1 year low of C$6.67 and a 1 year high of C$14.64. The firm’s 50-day simple moving average is C$8.07 and its 200-day simple moving average is C$9.32. The firm has a market cap of C$439.46 million, a PE ratio of 69.50, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65.

Vitalhub (TSE:VHI) last posted its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 EPS for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%.The business had revenue of C$31.39 million during the quarter. On average, equities analysts predict that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on VHI shares. ATB Cormark Capital Markets lowered their price target on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating for the company in a report on Tuesday, March 10th. Raymond James Financial reduced their price objective on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Tuesday. Scotiabank decreased their price objective on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Finally, Royal Bank Of Canada lowered their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research note on Monday, January 26th. One research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. Based on data from MarketBeat.com, Vitalhub presently has a consensus rating of “Buy” and an average target price of C$13.86.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.